-
14 November 2022
Global Fund Applauds UK Pledge to Seventh Replenishment
The Global Fund warmly welcomes the decision by the United Kingdom to renew its strong commitment to help end AIDS, tuberculosis and malaria and strengthen health and community systems around the world. Minister for Development Andrew Mitchell announ... -
22 September 2022
The Global Fund Signs Agreement with Pfizer to Expand Access to PAXLOVID™ Antiviral
The Global Fund to Fight AIDS, TB and Malaria has signed an agreement with Pfizer for the procurement of the new oral antiviral medicine nirmatrelvir/ritonavir, sold under the name PAXLOVID™ -
21 September 2022
Global Fund Private Sector Partners Pledge Record Levels of Support to End AIDS, TB, Malaria and Strengthen Systems for Health
-
21 September 2022
Global Fund Partners Pledge Record Level of Support to End Deadly Diseases, Prevent Future Pandemics
The United States of America-hosted pledging conference for the Global Fund to Fight AIDS, Tuberculosis and Malaria raised more than US$14.25 billion so far for the partnership’s work over the next three years. The conference in the margins of the UN... -
20 September 2022
Global Fund Approves Emergency Funding to Help Maintain Essential Health Services in Pakistan
The Global Fund to Fight AIDS, Tuberculosis and Malaria has approved US$10 million in emergency funding to ensure access and distribution of essential medicines and health services in Pakistan. -
12 September 2022
New Global Fund Report Shows 50 Million Lives Saved Over 20 Years in Fight Against HIV, TB and Malaria; Pandemic Investments Paying Off
The Global Fund’s 2022 Results Report released today finds a significant rebound in 2021 for programs working to defeat HIV, tuberculosis (TB) and malaria. In 2020, the COVID-19 pandemic had a devastating impact on the fight against the three disease...